{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9213607", "DateCompleted": {"Year": "1997", "Month": "07", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "51", "Issue": "1-3", "PubDate": {"Year": "1996", "Month": "Apr"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Medicinal plant genetic resources and international cooperation: the Brazilian perspective.", "Pagination": {"StartPage": "111", "EndPage": "120", "MedlinePgn": "111-9; discussion 119-20"}, "Abstract": {"AbstractText": ["Brazil is a gene rich country, host to 24% of known primate species, between 10 and 15 million species of insects, and 22% of the world's higher plant species. The debate over how and by whom these resources should be protected has intensified over the last few years due to a growing awareness of the links between sustainable utilization of natural resources, conservation of biodiversity, and economic development. Within this context the pharmaceutical exploitation of natural products for drug development has a prominent place. For a significant portion of Brazilian society, fair cooperation is welcome and can facilitate drug discovery. Nevertheless, the complexity of the consequences of patenting and utilization of natural resources calls for a thorough cost/benefit analysis in order to promote policies that can ensure significant and long term benefits for the country."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacologia, UFRGS, Porto Alegre, Brazil."}], "LastName": "Elisabetsky", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Costa-Campos", "ForeName": "L", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": ["economics", "legislation & jurisprudence"], "DescriptorName": "Conservation of Natural Resources"}, {"QualifierName": [], "DescriptorName": "Cost-Benefit Analysis"}, {"QualifierName": ["economics"], "DescriptorName": "Developing Countries"}, {"QualifierName": ["economics"], "DescriptorName": "Drug Industry"}, {"QualifierName": [], "DescriptorName": "Economics"}, {"QualifierName": [], "DescriptorName": "Ecosystem"}, {"QualifierName": [], "DescriptorName": "Intellectual Property"}, {"QualifierName": [], "DescriptorName": "International Cooperation"}, {"QualifierName": [], "DescriptorName": "Patents as Topic"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Pharmaceutical Preparations"}, {"QualifierName": ["economics"], "DescriptorName": "Pharmacognosy"}, {"QualifierName": ["genetics"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Public Policy"}, {"QualifierName": [], "DescriptorName": "Taxes"}], "NumberOfReferences": "19"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "4", "Day": "1"}, {"Year": "1996", "Month": "4", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "4", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9213607", "10.1016/0378-8741(95)01353-9", "0378-8741(95)01353-9"]}}]}